Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

December 23, 2016

Conditions
Parkinson Disease
Interventions
DEVICE

Spectramax light therapy device

Spectramax light therapy device emits a specific combination of bandwidths and intensities of light.

DEVICE

Control light device

The control light device is identical in appearance to the Spectramax light therapy device, except that when turned on, emits a different combination of bandwidths and intensity, not believed to produce a therapeutic response.

Trial Locations (3)

1007

VU University Medical Center (VUmc), Amsterdam

84058

Aspen Clinical Research, Orem

02114

Massachusetts General Hospital (MGH), Boston

Sponsors
All Listed Sponsors
lead

PhotoPharmics, Inc.

INDUSTRY